title: Conjugate heptavalent pneumococcal vaccine outcome improvements.
abstract: Heptavalent conjugate pneumococcal vaccine (PCV7) is now routinely administered to infants. Medical records from a pediatric outpatient clinic were used to identify two study groups: 1) those born between January 1995-May 1997(controls), 2) those born between April 2000--May 2001 (PCV7 group). The PCV7 group showed a lower incidence of otitis media episodes, clinic visits for fever and respiratory symptoms, antibiotic prescriptions, ceftriaxone use, and hospitalizations (singled sided probabilities).
authors.affiliation: Department of Pediatrics, University of Hawai'i, John A. Burns School of Medicine, Honolulu, HI 96813, USA.
authors.forename: George C
authors.initials: GC
authors.lastname: Balazs
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Garcia
authors.forename: Loren G
authors.initials: LG
authors.lastname: Yamamoto
mesh_terms: D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines; D016896:Treatment Outcome; D014611:Vaccination
chemical_list: D022242:Pneumococcal Vaccines